Logo image of SABR

SABRE CORP (SABR) Stock Fundamental Analysis

NASDAQ:SABR - Nasdaq - US78573M1045 - Common Stock - Currency: USD

4.52  +0.37 (+8.92%)

After market: 4.36 -0.16 (-3.54%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SABR. SABR was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of SABR have multiple concerns. SABR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SABR had negative earnings in the past year.
SABR had a positive operating cash flow in the past year.
SABR had negative earnings in each of the past 5 years.
In the past 5 years SABR reported 4 times negative operating cash flow.
SABR Yearly Net Income VS EBIT VS OCF VS FCFSABR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M -1B

1.2 Ratios

SABR has a Return On Assets of -6.40%. This is amonst the worse of the industry: SABR underperforms 83.21% of its industry peers.
SABR has a Return On Invested Capital (6.30%) which is in line with its industry peers.
Industry RankSector Rank
ROA -6.4%
ROE N/A
ROIC 6.3%
ROA(3y)-12.92%
ROA(5y)-11.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SABR Yearly ROA, ROE, ROICSABR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400

1.3 Margins

SABR has a Operating Margin (9.35%) which is comparable to the rest of the industry.
SABR's Operating Margin has declined in the last couple of years.
SABR's Gross Margin of 58.80% is fine compared to the rest of the industry. SABR outperforms 71.76% of its industry peers.
SABR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.35%
PM (TTM) N/A
GM 58.8%
OM growth 3YN/A
OM growth 5Y-31.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.61%
GM growth 5Y14.66%
SABR Yearly Profit, Operating, Gross MarginsSABR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SABR is destroying value.
SABR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SABR Yearly Shares OutstandingSABR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
SABR Yearly Total Debt VS Total AssetsSABR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

SABR has an Altman-Z score of -0.27. This is a bad value and indicates that SABR is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.27, SABR is not doing good in the industry: 87.02% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACC0.7
WACC9.05%
SABR Yearly LT Debt VS Equity VS FCFSABR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B

2.3 Liquidity

SABR has a Current Ratio of 1.02. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SABR (1.02) is comparable to the rest of the industry.
SABR has a Quick Ratio of 1.02. This is a normal value and indicates that SABR is financially healthy and should not expect problems in meeting its short term obligations.
SABR's Quick ratio of 1.02 is fine compared to the rest of the industry. SABR outperforms 61.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
SABR Yearly Current Assets VS Current LiabilitesSABR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

3. Growth

3.1 Past

SABR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.15%, which is quite impressive.
EPS 1Y (TTM)64.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.03%

3.2 Future

Based on estimates for the next years, SABR will show a very strong growth in Earnings Per Share. The EPS will grow by 38.01% on average per year.
Based on estimates for the next years, SABR will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y203.29%
EPS Next 2Y87.63%
EPS Next 3Y53.03%
EPS Next 5Y38.01%
Revenue Next Year5.15%
Revenue Next 2Y4.56%
Revenue Next 3Y3.52%
Revenue Next 5Y5.57%

3.3 Evolution

SABR Yearly Revenue VS EstimatesSABR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
SABR Yearly EPS VS EstimatesSABR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 -2 -3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

SABR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 23.03, the valuation of SABR can be described as rather expensive.
64.12% of the companies in the same industry are more expensive than SABR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.68. SABR is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 23.03
SABR Price Earnings VS Forward Price EarningsSABR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

SABR's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.42
SABR Per share dataSABR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SABR's earnings are expected to grow with 53.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y87.63%
EPS Next 3Y53.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SABR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SABRE CORP

NASDAQ:SABR (2/21/2025, 8:00:01 PM)

After market: 4.36 -0.16 (-3.54%)

4.52

+0.37 (+8.92%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners97.37%
Inst Owner Change3.54%
Ins Owners2.12%
Ins Owner Change2.81%
Market Cap1.74B
Analysts50.77
Price Target4.49 (-0.66%)
Short Float %5.22%
Short Ratio4.87
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)-39.54%
DP-0.01%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.34%
Min EPS beat(2)-12.04%
Max EPS beat(2)38.73%
EPS beat(4)3
Avg EPS beat(4)31%
Min EPS beat(4)-12.04%
Max EPS beat(4)79.89%
EPS beat(8)5
Avg EPS beat(8)18.72%
EPS beat(12)7
Avg EPS beat(12)15%
EPS beat(16)9
Avg EPS beat(16)9.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.9%
Min Revenue beat(2)-3.32%
Max Revenue beat(2)-0.48%
Revenue beat(4)1
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)2.15%
Revenue beat(8)2
Avg Revenue beat(8)-1.57%
Revenue beat(12)3
Avg Revenue beat(12)-1.26%
Revenue beat(16)4
Avg Revenue beat(16)-2.66%
PT rev (1m)-3.72%
PT rev (3m)-0.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-5.19%
Revenue NQ rev (1m)-0.62%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.03
P/S 0.58
P/FCF N/A
P/OCF 20.87
P/B N/A
P/tB N/A
EV/EBITDA 14.42
EPS(TTM)-0.19
EYN/A
EPS(NY)0.2
Fwd EY4.34%
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.22
OCFY4.79%
SpS7.78
BVpS-4.04
TBVpS-11.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.4%
ROE N/A
ROCE 7.98%
ROIC 6.3%
ROICexc 7.78%
ROICexgc N/A
OM 9.35%
PM (TTM) N/A
GM 58.8%
FCFM N/A
ROA(3y)-12.92%
ROA(5y)-11.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-7.17%
ROICexc growth 3YN/A
ROICexc growth 5Y-31.33%
OM growth 3YN/A
OM growth 5Y-31.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.61%
GM growth 5Y14.66%
F-Score5
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 11.58
Cap/Depr 65.32%
Cap/Sales 2.89%
Interest Coverage 250
Cash Conversion 20.19%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z -0.27
F-Score5
WACC9.05%
ROIC/WACC0.7
Cap/Depr(3y)39.05%
Cap/Depr(5y)32.59%
Cap/Sales(3y)2.99%
Cap/Sales(5y)3.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y203.29%
EPS Next 2Y87.63%
EPS Next 3Y53.03%
EPS Next 5Y38.01%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.03%
Revenue Next Year5.15%
Revenue Next 2Y4.56%
Revenue Next 3Y3.52%
Revenue Next 5Y5.57%
EBIT growth 1Y1045.52%
EBIT growth 3YN/A
EBIT growth 5Y-35.58%
EBIT Next Year129.89%
EBIT Next 3Y46.04%
EBIT Next 5Y26.3%
FCF growth 1Y99.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y125.66%
OCF growth 3YN/A
OCF growth 5Y-40.09%